Overexpression of a family of RPEL proteins modifies cell shape  by Favot, Laure et al.
FEBS Letters 579 (2005) 100–104 FEBS 29092Overexpression of a family of RPEL proteins modiﬁes cell shape
Laure Favot, Marc Gillingwater, Caroline Scott, Paul R. Kemp*
Department of Biochemistry, University of Cambridge, Building O, Downing Site, Tennis Court Road, Cambridge CB2 1QW, UK
Received 25 October 2004; revised 1 November 2004; accepted 4 November 2004
Available online 30 November 2004
Edited by Veli-Pekka LehtoAbstract Proteins containing RPEL motifs (e.g., MAL) are
important in the regulation of gene expression by the actin cyto-
skeleton. Screening the ENSEMBL database for RPEL proteins
identiﬁed four additional proteins that contain RPEL motifs and
nuclear localisation sequences, three of which (RPEL-A, RPEL-
B and RPEL-C) are expressed in adult mouse tissues with diﬀer-
ent expression proﬁles. The mRNAs encoding RPEL-B and
RPEL-C were subject to alternative splicing. Expression of these
genes in cells indicated that they had a marked eﬀect on cell
shape. Furthermore, when expressed with a nuclear localised ac-
tin all of the diﬀerent forms became restricted to the nucleus.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.











In addition to providing structure to cells, the cytoskeleton is
an important contributor to cell adhesion, cell movement and
cell shape through the formation of lamellipodia and ﬁlopodia.
The cytoskeleton is also an important regulator of gene expres-
sion and the degree of actin polymerisation regulates the
expression of genes that encode cytoskeletal components
[1,2]. Increased actin polymerisation has been shown to in-
crease the activity of the transcription factor serum response
factor (SRF). One mechanism by which this increase in activity
has been suggested to occur is through the re-localisation of
the SRF co-activator MAL from the cytoplasm to the nucleus
in the presence of polymerised actin or the activation of the
small monomeric GTPase Rho [3]. MAL has been shown to
bind to unpolymerised actin (G-actin) and in the presence of
excess G-actin MAL is retained in the cytoplasm. In the ab-
sence of G-actin MAL moves into the nucleus. MAL contains
three repeats of an RPEL motif (RPXXXEL) that are required
for it to bind to actin [3]. These data suggest that other
proteins with RPEL repeats may be important actin binding
proteins.
We screened the ENSEMBL database and identiﬁed a small
family of genes that encoded RPEL containing proteins. All of
the proteins identiﬁed contained nuclear localisation sequences
(NLSs), suggesting that they may integrate nuclear and cyto-
plasmic functions. In this report, we describe the cloning and
tissue distribution of these genes. Furthermore, we examine*Corresponding author. Fax +1223 333345.
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doi:10.1016/j.febslet.2004.11.054the localisation of the proteins, their ability to interact with ac-
tin, eﬀect on cell shape and on promoter activity.2. Materials and methods
2.1. Plasmids, RT-PCR and cloning
pSM22a-197-luc was derived from pSM22a-197-CAT by subcloning
the pSM22a-197 promoter into pGL3. The actin-NLS vectors were a
generous gift from Dr. Richard Treisman. RT-PCR was performed
as described previously [4], on RNA isolated from mouse tissues using
the RNeasy kit. RPEL cDNA was ampliﬁed using the appropriate
primers and cloned into pGEM-T easy (Promega). Clones with the
correct open reading frame were subcloned into pcDNA3 using EcoRV
and Not1 sites. To make EGFP-fusion proteins, the EcorV–NotI frag-
ments were cloned in frame with an N-terminal EGFP gene in
pCDNA3.2.2. Primers2.3. Cell culture and luciferase assays
C2C12 cells were grown as described previously [5]. Cells were
seeded into 24 wells plates at a cell density of 1.8 · 104 cells/well. After
24 h, the cells were washed with serum free DMEM and incubated with
a mixture of 400 ng of DNA (made up as indicated in the legends)
complexed with 2 ll of lipofectamine (Invitrogen) in OptiMEM (Invit-
rogen). Cells were incubated with the lipid/DNA mixture for 5 h before
the medium was replaced with DMEM supplemented with 10% FCS.
Forty-eight hours after transfection, Fireﬂy and Renilla luciferase
activity were measured using the Dual-Luciferase reporter assay
(Promega).2.4. Fluorescence microscopy
For determination of RPEL localisation, C2C12 cells were seeded
into 4 well lab-tek chamber slides (Nunc) at a cell density of
1.5 · 104 cells/well. The cells were transfected 24 h later with 470 ng
of DNA (as indicated in the ﬁgure legends) and 2 ll of lipofectamine
as above. Cells were ﬁxed 24 h later with 4% paraformaldehyde in
PBS for 15 min and washed prior to imaging. To detect FLAG tagged
actins, ﬁxed cells were permeabilised for 10 min in 0.3% Triton X-100
in PBS, incubated for 30 min in PBS containing 1% BSA followed by 1
h with anti-M2 ﬂag antibody (Sigma) and 1 h with anti rabbit-Cy3
antibody (Jackson). Images were captured using an Olympus TX 70 in-
verted microscope coupled to Ultraview LCI confocal imaging system
(Perkin–Elmer) in the epiﬂuorescence mode.blished by Elsevier B.V. All rights reserved.
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3.1. Cloning and tissue distribution of the RPEL genes
We screened the ENSEMBL database (www.ensembl.org)
for genes that encoded proteins with an RPEL motif. This
analysis showed that the mouse genome contained 7 such
genes, three of which were known (MAL [3], MRTF-B [6] andFig. 1. Tissue distribution of RPEL gene expression. RT-PCR for RPEL-A,
tissues and analysed on a 1% agarose gel. Markers are Hyperladder I (Bioli
Fig. 2. Alignment of the protein sequences for the RPEL proteins. Amino a
motifs (solid lines) and the NLS (dotted lines) are underlined.myocardin [7]). However, four sequences were from
predicted but unidentiﬁed genes (ENSMUSG00000027525,
ENSMUSG00000028897, ENSMUSG00000038587 and ENS-
MUSG00000053616). To determine whether these genes were
expressed in the adult mouse and to obtain clones for them,
primers were designed to amplify each of the coding sequences
and used in RT-PCRs. RT-PCR for RPEL-A using primers-B, -CS and -CL was performed on RNA isolated from the indicated
ne).
cids identical in two or more of the sequences are shaded. The RPEL
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mately 2 kb from brain but not from any other tissue (Fig. 1).
Cloning and sequencing of this product showed that it encoded
a protein identical to that encoded by ENSMUSG00000027525.
RT-PCR for RPEL-B using primers RPELBF and RPELBR
produced a 2.2-kb PCR product from all the samples tested
(Fig. 1). Cloning and sequencing of the product identiﬁed it as
the transcript from the gene ENSMUSG00000028897.
Amongst the clones sequenced for RPEL-B was a product1 2 3 4 5 6 7
1 2 3 4 5 6




Fig. 3. Organisation of the RPEL genes. Intron–exon organisation of the RP
scale. The splicing pattern for the mRNAs identiﬁed is shown as dotted lines
with the putative additional promoter shown as an arrow. The diagram has b
indicated by the lines (RP = RPEL).
Fig. 4. Localisation of EGFP–RPEL proteins. C2C12 cells were transfected w
after transfection and analysed by epiﬂuorescence microscopy.164 bp shorter than the majority of the clones, suggesting that
RPEL-B is alternatively spliced (see below). RT-PCR using
primers RPELCF and RPELCR produced a 500-bp product
from the kidney, with weak PCR products also present in the
heart, lung and brain (Fig. 1). Cloning and sequencing con-
ﬁrmed that the product was the transcript from ENS-
MUSG000000385870. Comparison of this sequence with the
NR database identiﬁed an additional larger transcript with
the Accession No. NM_198419. We therefore termed the initial8 9 10 11 12 13
7 8 9 10
RP1 RP2 RP3
7 8 9 10 11 12
EL genes. Introns (lines) and Exons (numbered boxes) are not drawn to
and the extra sequence present in RPEL-CS is shown as a ﬁlled in box
een drawn to align the exons coding for each RPEL motif. RPELs are
ith 470 ng of EGFP–RPEL expression vector. The cells were ﬁxed 24 h
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(RPELCLF and RPELCLR) were designed. These reactions
produced a product of approximately 2 kb from the kidney
alone (Fig. 1). Cloning and sequencing of this product identiﬁed
two additional isoforms of RPEL-C, which diﬀered by approx-
imately 200 bp and were therefore named RPEL-CL1 and
RPEL-CL2. No product was obtained from primers for
RPEL-D from any of the samples used in the PCRs.3.2. Protein sequence comparison
Comparison of the coding sequences for the proteins indi-
cated that the C-termini of the proteins were approximately
90% similar and that all but RPEL-CS contained three RPEL
motifs and a NLS (Fig. 2). RPEL-CS contained the last two
RPEL motifs and the NLS. The N-terminal domains of all
of the proteins were very diﬀerent apart from a conserved
bipartite NLS in RPEL-A, RPEL-B and RPEL-CL (Fig. 2).
If RPEL-D is made as a protein, it is the most divergent of
the four members of this family. Whilst RPEL-D has all three
RPEL motifs and a NLS in the C-terminus it lacks the N-ter-
minal bipartite NLS and has a C-terminal extension not pres-
ent in the other proteins.3.3. Gene structure
Comparison of the cDNA sequences with the mouse genome
showed that the coding sequence of all of the genes was split
into at least 10 exons (12 exons for RPEL-A on chromosome
2, 10 exons for RPEL-B on chromosome 4 and 13 exons for
RPEL-C on chromosome 13, Fig. 3). The sequence lacking
in the shorter form of RPEL-B contained exon 2 of the coding
sequence (Fig. 3). Comparison of the diﬀerent isoforms of
RPEL-C indicated that the diﬀerence between RPEL-CL1
and RPEL-CL2 was the absence of exon 5 sequence in
RPEL-CL2 mRNA. Analysis of the RPEL-CS sequence
showed that RPEL-CS consisted of exons 9–13 of RPEL-
CL1 with an additional sequence at the 5 0-end of the RPEL-
CS cDNA that was not present in RPEL-CL1 or RPEL-
CL2. This additional sequence was found to be in the intron
upstream of RPEL-CL exon 9 (Fig. 3), suggesting that the
RPEL-C gene has two promoters, one driving expression of
RPEL-CL and one for RPEL-CS.Fig. 5. EGFP–RPEL proteins co-localise with nuclear targeted actin.
C2C12 cells were transfected with 350 ng of EGFP–RPEL expression
vector and 120 ng of pEF-FLAG actin expression vector. The cells
were ﬁxed 24 h after transfection, stained for FLAG as described in
Section 2 and analysed by epiﬂuorescence microscopy.3.4. Localisation of EGFP–RPEL proteins and eﬀect on cell
shape
As all of the proteins had at least one NLS as well as se-
quences previously shown to bind to actin, we generated N-ter-
minal EGFP–RPEL fusion proteins expression vectors to
determine whether the expressed proteins became localised to
one speciﬁc compartment or were present throughout the cell.
Transfection of these vectors into C2C12 cells showed that all
of the proteins with the bipartite NLS (i.e., all except RPEL-
CS) were present throughout the cells (Fig. 4). Conversely,
approximately 50% of the cells expressing EGFP–RPEL-CS
showed nuclear exclusion of this protein (Fig. 4), raising the
possibility that the N-terminal NLS is important in nuclear
localisation. The cytoplasmic EGFP ﬂuorescence in cells trans-
fected with RPEL-A and RPEL-B was often distributed inho-
mogeneously with stronger ﬂuorescence at the edge of the cells
and punctate ﬂuorescence in the cytoplasm (Fig. 4). However,
this ﬂuorescence did not co-localise with staining for focal
adhesion kinase (data not shown).The long forms of the EGFP–RPEL fusion proteins had a
signiﬁcant eﬀect on cell shape (Fig. 4). Cells expressing these
proteins had a rough appearance rather than the smooth edges
of cells transfected with EGFP alone. All of the cells transfec-
ted with the fusion proteins for RPEL-A, B, C1 and C2 had
hair-like cytoplasmic extensions of varying lengths that were
not observed on the control cells (Fig. 4).
3.5. Association of the EGFP–RPEL proteins with actin
To determine the eﬀect of actin on RPEL localisation, cells
were transfected with the EGFP–RPEL fusion protein in the
presence of FLAG tagged wild-type actin or a mutant FLAG
tagged actin that contained a NLS [3]. Cotransfection of wild-
type actin had no eﬀect on the localisation of the EGFP–RPEL
proteins (Fig. 5). However, in the presence of the mutant actin
containing the NLS all of the EGFP–RPEL isoforms became
localised to the nucleus, indicating that the RPEL proteins
interact with actin (Fig. 5).
3.6. Eﬀect of the RPEL proteins on transcription
To determine whether these RPEL proteins modiﬁed gene
expression, their eﬀect on the activity of a fragment of the
SM22a promoter [8] (which is activated by MAL) was deter-
mined. In these experiments, the RPEL proteins caused a weak
inhibition of promoter activity (approximately 20%, Table 1).
Table 1
RPEL proteins are weak inhibitors of the SM22a promoter
Sample Control MAL RPEL-A RPEL-B RPEL-CS RPEL-CL1 RPEL-CL2
Fold activation 1 23 ± 1 0.69 ± 0.03 0.76 ± 0.05 0.72 ± 0.05 0.82 ± 0.02 0.82 ± 0.04
C2C12 cells were transfected with 200 ng of pSM22a-197-luc, 100 ng of pRL-TK and 50 ng each of RPEL or MAL in pCDNA3 and pCDNA3. Cells
were harvested 48 h after transfection for luciferase assays. The Fireﬂy luciferase activity was normalised to Renilla luciferase activity. Numbers are
fold activation of luciferase activity ± S.E.M. Transfections were set up in triplicate and repeated 3–6 times.
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which inhibited the SM22a promoter by approximately 30%.4. Discussion
We have identiﬁed and cloned a family of proteins that con-
tain RPEL motifs and NLSs. The NLSs are located both with-
in the RPEL motif domain and in the N-terminal region of the
larger protein isoforms. Expression of RPEL-B was found in
all of the tissues examined, suggesting a general role in cell
biology. However, two of the others were expressed in a tis-
sue-restricted fashion with RPEL-A restricted to the brain
and RPEL-CS and RPEL-CL expression found mainly in
the kidney. This implies that there are more specialised roles
for these members of the family either in terms of function
or the context within which they function. Two of the genes
produced more than one isoform by alternative splicing. How-
ever, there was no obvious similarity between the deleted re-
gions of RPEL-B and RPEL-CL and the role of the
alternative isoforms is not clear.
To determine the subcellular localisation of these proteins
requires the generation of speciﬁc antibodies for each of the
isoforms and these do not yet exist. In this study, we used
the expression of EGFP fusion proteins as a surrogate mea-
surement and therefore determined the localisation of exoge-
nous proteins. The subcellular localisation of the transfected
EGFP–RPEL proteins is consistent with the presence of NLSs
in the long isoforms and with their ability to interact with ac-
tin. During the course of this work, a study identifying scapa-
nin (the human form of RPEL-A) was published [9].
Consistent with the ﬁndings presented here, they found that
the protein was present in both the nucleus and the cytoplasm
of transfected HeLa cells using antibodies and EGFP-fusion
proteins. The localisation of these proteins is also consistent
with the localisation of MAL in the same cells under serum
stimulated conditions (LF unpublished observations).
RPEL containing proteins are found in a wide range of meta-
zoan organisms and at least one protein from each of Caenor-
habditis elegans, Drosophila melanogaster and Danio Rerio
have a R-X-X-P-W-K-W-(R/K)-X0–2-(K/R)-(K/R)-(K/R) mo-
tif, similar to part of the bipartite NLS found in the long forms
of the RPEL proteins. The conservation of this sequence across
a diverse range of species and a protein family suggests that it is
important in the function of the proteins and indicates that the
proteins may be involved in nuclear processes.
Consistent with an ability to interact with actin, the EGFP–
RPEL proteins caused signiﬁcant modiﬁcation in cell shape. It
is of interest that expression of one of the proteins, RPEL-A, is
restricted to the brain, suggesting that it may be involved in the
regulation of cell shape in neural cells. Alternatively, the pro-
teins may be involved in cell movement as the transfected cells
had a tendency to detach from the substrate (data not shown).
However, the eﬀect of these proteins on cell shape is not just aresult of the interaction between actin and the RPEL motifs
because other RPEL containing proteins (e.g., MAL) do not
have the same eﬀect.
Whether this subfamily of RPEL proteins is involved in the
regulation of gene expression remains to be determined. The
proteins have a limited eﬀect on the activity of an SM22a re-
porter gene, suggesting that they do not aﬀect SRF activity,
consistent with the lack of an SRF interacting SAP domain.
However, the interaction of the proteins with actin suggests
that they may compete for actin binding with MAL. Such a
competition for G-actin should have led to nuclear localisation
of MAL, activation of SRF and thereby increased promoter
activity rather than the inhibition of promoter activity seen
here. Therefore, the data imply a more complex method of reg-
ulation of MAL.
In conclusion, we have analysed a family of proteins that
contain multiple RPEL motifs. The members of the family
show diﬀerent tissue speciﬁc expression patterns and are able
to modify cell shape.Acknowledgments: This work was supported by the British Heart
Foundation. P.R.K. is a British Heart Foundation Basic Sciences
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